The Impact of COVID-19 is included in Neurological Biomarker Market Report. Buy it today to get an advantage.
Request the impact of COVID-19 on your product or industry
Neurological Biomarker Trends and Forecast
The future of the global neurological biomarker market looks promising with opportunities in the hospital & hospital laboratory, independent clinical diagnostic center, and research organizations markets. The global neurological biomarker market is expected to reach an estimated $14.7 billion by 2030 with a CAGR of 11.7% from 2024 to 2030. The major drivers for this market are growing adoption of liquid biopsy, increasing utilization of artificial intelligence (AI) in neurological biomarker development, and rising demand for personalized medicine.
A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown below.
Neurological Biomarker by Segment
The study includes a forecast for the global neurological biomarker by type, application, end use, and region.
Neurological Biomarker Market by Type [Shipment Analysis by Value from 2018 to 2030]:
• Genomic
• Proteomic
• Metabolomic
• Imaging
• Others
Neurological Biomarker Market by Application [Shipment Analysis by Value from 2018 to 2030]:
• Alzheimer’S Disease
• Parkinson’S Disease
• Multiple Sclerosis
• Autism Spectrum Disorder
• Others
Neurological Biomarker Market by End Use [Shipment Analysis by Value from 2018 to 2030]:
• Hospital & Hospital Laboratories
• Independent Clinical Diagnostic Centers
• Research Organizations and Others
Neurological Biomarker Market by Region [Shipment Analysis by Value from 2018 to 2030]:
• North America
• Europe
• Asia Pacific
• The Rest of the World
List of Neurological Biomarker Companies
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies neurological biomarker companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the neurological biomarker companies profiled in this report include-
• Abbott
• Thermo Fisher Scientific
• Bio-Rad Laboratories
• Merck
• Johnson & Johnson Services
• Banyan Biomarkers
• Myriad Genetics
Neurological Biomarker Market Insights
Lucintel forecasts that proteomic is expected to witness highest growth over the forecast period due to increasing prevalence of neurological diseases.
Within this market, hospitals and hospital laboratories will witness the highest growth as they are considered as a primary providers of diagnostic services for neurological disorders.
North America will remain the largest region over the forecast period due to high prevalence of neurological disorders, such as alzheimerÄX%$%Xs disease, parkinsonÄX%$%Xs disease, and multiple sclerosis and rising healthcare expenditure in the region.
Features of the Global Neurological Biomarker Market
Market Size Estimates: Neurological biomarker market size estimation in terms of value ($B).
Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.
Segmentation Analysis: Neurological biomarker market size by type, application, end use, and region in terms of value ($B).
Regional Analysis: Neurological biomarker market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
Growth Opportunities: Analysis of growth opportunities in different type, application, end use, and regions for the neurological biomarker market.
Strategic Analysis: This includes M&A, new product development, and competitive landscape of the neurological biomarker market.
Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
FAQ
Q.1 What is the neurological biomarker market size?
Answer: The global neurological biomarker market is expected to reach an estimated $14.7 billion by 2030.
Q.2 What is the growth forecast for neurological biomarker market?
Answer: The global neurological biomarker market is expected to grow with a CAGR of 11.7% from 2024 to 2030.
Q.3 What are the major drivers influencing the growth of the neurological biomarker market?
Answer: The major drivers for this market are growing adoption of liquid biopsy, increasing utilization of artificial intelligence (AI) in neurological biomarker development, and rising demand for personalized medicine.
Q4. What are the major segments for neurological biomarker market?
Answer: The future of the neurological biomarker market looks promising with opportunities in the hospital & hospital laboratory, independent clinical diagnostic center, and research organizations markets.
Q5. Who are the key neurological biomarker market companies?
Answer: Some of the key neurological biomarker companies are as follows:
• Abbott
• Thermo Fisher Scientific
• Bio-Rad Laboratories
• Merck
• Johnson & Johnson Services
• Banyan Biomarkers
• Myriad Genetics
Q6. Which neurological biomarker market segment will be the largest in future?
Answer: Lucintel forecasts that proteomic is expected to witness highest growth over the forecast period due to increasing prevalence of neurological diseases.
Q7. In neurological biomarker market, which region is expected to be the largest in next 5 years?
Answer: North America will remain the largest region over the forecast period due to high prevalence of neurological disorders, such as alzheimerÄX%$%Xs disease, parkinsonÄX%$%Xs disease, and multiple sclerosis and rising healthcare expenditure in the region.
Q.8 Do we receive customization in this report?
Answer: Yes, Lucintel provides 10% customization without any additional cost.
This report answers following 11 key questions:
Q.1. What are some of the most promising, high-growth opportunities for the neurological biomarker market by type (genomic, proteomic, metabolomic, imaging, and others), application (alzheimer’s disease, parkinson’s disease, multiple sclerosis, autism spectrum disorder, and others), end use (hospital & hospital laboratories, independent clinical diagnostic centers, and research organizations and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?
For any questions related to Neurological Biomarker Market, Neurological Biomarker Market Size, Neurological Biomarker Market Growth, Neurological Biomarker Market Analysis, Neurological Biomarker Market Report, Neurological Biomarker Market Share, Neurological Biomarker Market Trends, Neurological Biomarker Market Forecast, Neurological Biomarker Companies, write Lucintel analyst at email: helpdesk@lucintel.com. We will be glad to get back to you soon.
Table of Contents
1. Executive Summary
2. Global Neurological Biomarker Market : Market Dynamics
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
3. Market Trends and Forecast Analysis from 2018 to 2030
3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
3.2. Global Neurological Biomarker Market Trends (2018-2023) and Forecast (2024-2030)
3.3: Global Neurological Biomarker Market by Type
3.3.1: Genomic
3.3.2: Proteomic
3.3.3: Metabolomic
3.3.4: Imaging
3.3.5: Others
3.4: Global Neurological Biomarker Market by Application
3.4.1: Alzheimer’s Disease
3.4.2: Parkinson’s Disease
3.4.3: Multiple Sclerosis
3.4.4: Autism Spectrum Disorder
3.4.5: Others
3.5: Global Neurological Biomarker Market by End Use
3.5.1: Hospital & Hospital Laboratories
3.5.2: Independent Clinical Diagnostic Centers
3.5.3: Research Organizations and Others
4. Market Trends and Forecast Analysis by Region from 2018 to 2030
4.1: Global Neurological Biomarker Market by Region
4.2: North American Neurological Biomarker Market
4.2.2: North American Neurological Biomarker Market by End Use: Hospital & Hospital Laboratories, Independent Clinical Diagnostic Centers, and Research Organizations and Others
4.3: European Neurological Biomarker Market
4.3.1: European Neurological Biomarker Market by Type: Genomic, Proteomic, Metabolomic, Imaging, and Others
4.3.2: European Neurological Biomarker Market by End Use: Hospital & Hospital Laboratories, Independent Clinical Diagnostic Centers, and Research Organizations and Others
4.4: APAC Neurological Biomarker Market
4.4.1: APAC Neurological Biomarker Market by Type: Genomic, Proteomic, Metabolomic, Imaging, and Others
4.4.2: APAC Neurological Biomarker Market by End Use: Hospital & Hospital Laboratories, Independent Clinical Diagnostic Centers, and Research Organizations and Others
4.5: ROW Neurological Biomarker Market
4.5.1: ROW Neurological Biomarker Market by Type: Genomic, Proteomic, Metabolomic, Imaging, and Others
4.5.2: ROW Neurological Biomarker Market by End Use: Hospital & Hospital Laboratories, Independent Clinical Diagnostic Centers, and Research Organizations and Others
5. Competitor Analysis
5.1: Product Portfolio Analysis
5.2: Operational Integration
5.3: Porter’s Five Forces Analysis
6. Growth Opportunities and Strategic Analysis
6.1: Growth Opportunity Analysis
6.1.1: Growth Opportunities for the Global Neurological Biomarker Market by Type
6.1.2: Growth Opportunities for the Global Neurological Biomarker Market by Application
6.1.3: Growth Opportunities for the Global Neurological Biomarker Market by End Use
6.1.4: Growth Opportunities for the Global Neurological Biomarker Market by Region
6.2: Emerging Trends in the Global Neurological Biomarker Market
6.3: Strategic Analysis
6.3.1: New Product Development
6.3.2: Capacity Expansion of the Global Neurological Biomarker Market
6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Neurological Biomarker Market
6.3.4: Certification and Licensing
7. Company Profiles of Leading Players
7.1: Abbott
7.2: Thermo Fisher Scientific
7.3: Bio-Rad Laboratories
7.4: Merck
7.5: Johnson & Johnson Services
7.6: BANYAN BIOMARKERS
7.7: Myriad Genetics
.
Buy full report or by chapter as follows
Lucintel has been in the business of market research and management consulting since 2000 and has published over 1000 market intelligence reports in various markets / applications and served over 1,000 clients worldwide. This study is a culmination of four months of full-time effort performed by Lucintel's analyst team. The analysts used the following sources for the creation and completion of this valuable report:
In-depth interviews of the major players in this market
Detailed secondary research from competitors’ financial statements and published data
Extensive searches of published works, market, and database information pertaining to industry news, company press releases, and customer intentions
A compilation of the experiences, judgments, and insights of Lucintel’s professionals, who have analyzed and tracked this market over the years.
Extensive research and interviews are conducted across the supply chain of this market to estimate market share, market size, trends, drivers, challenges, and forecasts. Below is a brief summary of the primary interviews that were conducted by job function for this report.
Thus, Lucintel compiles vast amounts of data from numerous sources, validates the integrity of that data, and performs a comprehensive analysis. Lucintel then organizes the data, its findings, and insights into a concise report designed to support the strategic decision-making process. The figure below is a graphical representation of Lucintel’s research process.
Please sign in below to get report brochure - Neurological Biomarker Market Report.